Cytokinetics Inc (NASDAQ:CYTK)
| 9.51 Delayed Data As of Dec 11 |  +0.02 / +0.21%Today’s Change | 5.75 Today|||52-Week Range 14.94 | +50.47% Year-to-Date |
Latest CYTK News | Press Releases
No recent news for Cytokinetics Inc.
Today’s Trading
| Previous close | 9.49 |
| Today’s open | 9.51 |
| Day’s range | 9.43 - 9.67 |
| Volume | 958,820 |
| Average volume (3 months) | 650,417 |
| Market cap | $556.0M |
Data as of 3:59pm ET, 12/11/2019
Growth & Valuation
| Earnings growth (last year) | +24.59% |
| Earnings growth (this year) | -4.19% |
| Earnings growth (next 5 years) | +1.00% |
| Revenue growth (last year) | +135.64% |
| P/E ratio | NM |
| Price/Sales | 10.92 |
| Price/Book | 19.85 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BDSIBioDelivery Sciences... | -0.09 | -1.40% |
| VKTXViking Therapeutics ... | -0.06 | -0.78% |
| ACIUAC Immune SA | +0.17 | +2.03% |
| PRVBProvention Bio Inc | -0.34 | -2.92% |
Data as of 4:00pm ET, 12/11/2019
Financials
| Next reporting date | February 13, 2020 |
| EPS forecast (this quarter) | -$0.48 |
| Annual revenue (last year) | $31.5M |
| Annual profit (last year) | -$106.3M |
| Net profit margin | -337.41% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters South San Francisco, California |
Forecasts
